期刊
NATURE REVIEWS ENDOCRINOLOGY
卷 9, 期 12, 页码 697-698出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrendo.2013.221
关键词
-
Alefacept, a fusion protein approved for psoriasis, has been Walled in patients with new-onset type 1 diabetes mellitus. However, the withdrawal of the drug from the US market and the unmet primary end point do not raise hope for this drug, even though some secondary end points were met and the study highlighted interesting immunological efficacy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据